|
New SA Article from George Rho
|
2
|
Mannkind
|
Jun 19, 2013 08:07AM
|
|
Re: Copy of Joe Springer Article - 5 Reasons MannKind Could Be The Best Performing S
|
|
Mannkind
|
Jun 21, 2013 08:52PM
|
|
Re: Copy of Joe Springer Article - 5 Reasons MannKind Could Be The Best Performing S
|
2
|
Mannkind
|
Jun 22, 2013 01:13PM
|
|
Piper Jaffray raises price target
|
4
|
Mannkind
|
Jun 26, 2013 08:32AM
|
|
MLV raises price target
|
1
|
Mannkind
|
Jun 27, 2013 07:31AM
|
|
Re: MLV raises price target
|
|
Mannkind
|
Jun 27, 2013 07:55AM
|
|
Re: New SA Article
|
2
|
Mannkind
|
Jun 27, 2013 09:25AM
|
|
Re: New SA Article
|
|
Mannkind
|
Jun 27, 2013 06:02PM
|
|
Class action suit - old news?
|
|
Mannkind
|
Jun 28, 2013 07:15AM
|
|
Re: Lyxumia® is First Diabetes Therapy of its Class Approved in Japan for use in Com
|
1
|
Mannkind
|
Jun 28, 2013 10:12AM
|
|
Re: MannKind announces $160M debt financing
|
|
Mannkind
|
Jul 01, 2013 09:38AM
|
|
Re: Deerfield financing Deal
|
|
Mannkind
|
Jul 02, 2013 07:22AM
|
|
Re: MannKind announces $160M debt financing
|
|
Mannkind
|
Jul 02, 2013 10:56AM
|
|
Re: Insider Trading Alert - Chesapeake Energy And 3 Others Traded By Insiders
|
|
Mannkind
|
Jul 05, 2013 07:05PM
|
|
Re: Wells Fargo Conference
|
1
|
Mannkind
|
Jul 05, 2013 09:28PM
|
|
Happy 4th
|
5
|
Mannkind
|
Jul 05, 2013 09:30PM
|
|
Re: Inhaled Insulin: Biotech Triumph or Future Flop?
|
4
|
Mannkind
|
Jul 07, 2013 05:14PM
|
|
Re: A Leading Indicator Of Success: Failure And Risk In Biotechnology
|
2
|
Mannkind
|
Jul 08, 2013 05:24PM
|
|
Re: New medicine
|
|
Mannkind
|
Jul 10, 2013 08:03PM
|
|
Re: PPS Based upon project new capacity of 4 lines
|
|
Mannkind
|
Jul 12, 2013 05:06PM
|
